TomoTherapy Co-Founder to Speak at North Carolina IMRT/IGRT Symposium
MADISON, Wis. (Business Wire EON) April 7, 2008 --
TomoTherapy Incorporated (NASDAQ:
TOMO) announced today that company co-founder Thomas “Rock”
Mackie, Ph.D., will speak at an upcoming symposium on
intensity-modulated and image-guided radiation therapy (IMRT/IGRT). The
symposium, co-sponsored by Duke University and East Carolina University,
will be held on April 19, 2008 in Greenville, N.C. Dr. Mackie will
discuss the clinical advantages of TomoTherapy’s
unique, highly-modulated mode of radiation delivery.
“I am honored to accept this invitation to
speak,” said Dr. Mackie. “I
look forward to the opportunity to discuss with my colleagues how
helical TomoTherapy®
is able to achieve consistently high-quality dose distributions across a
wide range of cases. We’ve effectively
eliminated the need for clinical reliance upon complex techniques such
as non-axial or non-coplanar arcs.”
The TomoTherapy® Hi·Art®
treatment system is a novel radiation therapy platform that uses a
patented binary multi-leaf collimator (MLC) to modulate the radiation
beam as it rotates around the patient. The system includes integrated 3D
CT-based image guidance and adaptive radiation therapy, leveraging the
design advantages of a CT platform and the tight integration afforded by
a centralized planning, imaging and treatment database.
Dr. Mackie co-founded TomoTherapy with Paul Reckwerdt in 1997, and
currently serves as the company’s chairman of
the board. Dr. Mackie is also a professor in the departments of Medical
Physics and Human Oncology at the University of Wisconsin.
This will be the second annual North Carolina IMRT/IGRT Symposium. This
year’s theme is Integrating New Technology
in Radiation Oncology. In speaking at this event, Dr. Mackie
will join professors and clinicians from East Carolina University School
of Medicine, Duke University Medical Center, University of North
Carolina at Chapel Hill School of Medicine, Wake Forest University, and
Baptist Medical Center.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy®
Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company’s stock is traded on the
NASDAQ Global Select Market under the symbol TOMO. To learn more about
TomoTherapy, please visit TomoTherapy.com.
©2008 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, the TomoTherapy logo and Hi·Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated.
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/Q291cC1DcmFzLVNxdWEtU3VtbS1TdW1tLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
